🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ANTOINE is a prospective trial which aims to assess diagnostic performance ...
Status
Completed
Location
Hospices Civils de Lyon
Start Date
2017-06-06
Trial ID
NCT03163628
Treatments Being Tested
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested
Rhesus conflict between mother and fetus is due to the different antigenic ...
Status
Unknown
Location
Municipal non-profit enterprise "Cherkasy Regional Hospital of Cherkasy Regional Council"
Start Date
2022-02-08
Trial ID
NCT05245734
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
Ceftobiprole, a fifth-generation cephalosporin, exhibits potent antibacteri...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-12
Trial ID
NCT07127185
Treatments Being Tested
The purpose of this study is to determine the average risk for thyroid irra...
Status
Completed
Location
Assistance Publique Hopitaux de Marseille
Start Date
2011-03
Trial ID
NCT01693796
Treatments Being Tested
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
In the unfortunate case of severe hypoglycaemia, glucagon is the first-line...
Status
Withdrawn
Location
Institut de recherches cliniques de Montréal
Start Date
2013-04
Trial ID
NCT01828125
Treatments Being Tested